Sleep Architecture and Recovery: What Actually Moves the Needle
Slow-wave sleep, REM proportion, and the interventions with real trial support — separated from wearable-vendor marketing.
Medically reviewed · 2025-06-18
Author
MS Exercise Physiology
Maya Okafor is an exercise physiologist and science writer covering recovery, sleep, and nutrition research. She spent six years in applied sport-science labs before moving to research communication, and writes with a simple rule: if a claim cannot survive its own citation, it does not ship.
Slow-wave sleep, REM proportion, and the interventions with real trial support — separated from wearable-vendor marketing.
Medically reviewed · 2025-06-18
What human crossover trials say about meal timing, glucose response, and training adaptations — and where the effect sizes get exaggerated.
Medically reviewed · 2025-06-10
STEP-trial weight loss near 15%, cardiovascular outcome data, a boxed warning, and an FDA-warned compounded gray market: the full semaglutide picture.
Medically reviewed · 2025-06-20

Sublingual semaglutide drops are compounded products with no published outcome trials. The approved oral tablet needed an absorption enhancer for a reason.
Medically reviewed · 2025-06-20

GH-axis timing rules trace to real physiology (insulin blunts GH release; pulses cluster in early sleep). Most other peptide timing rules trace to nothing.
Medically reviewed · 2025-06-20
Most peptide research enrolled male animals or male-heavy cohorts. What that gap means for women — plus the contraindications that apply specifically.
Medically reviewed · 2025-06-20
All content by this author is reviewed under our editorial policy.